Advertisement

Pulmonary MRA

  • Martin R. Prince
  • Thomas M. Grist
  • Jörg F. Debatin

Abstract

Pulmonary MR angiography (MRA) has faced the challenges of overcoming the problems of respiratory motion, cardiac pulsation, and susceptibility artifact at air-tissue interfaces yet still being able to resolve small sub-segmental pulmonary arteries. Early development of pulmonary MRA techniques focused on black blood and time-of-flight approaches. Neither of these has proven reliable. Three-dimensional (3D) contrast MRA now offers several advantages that make pulmonary MRA possible. The 3D spoiled gradient echo technique has an intrinsically short echo time (TE). With high performance gradients, echo times under 3 and even 1-2 ms are available. These are sufficient to eliminate susceptibility artifact. Due to the enhancement with paramagnetic contrast, 3D contrast MRA is less affected by inflow variations that create pulsation artifact on time-of-flight and phase contrast imaging. Breath-holding eliminates respiratory motion artifact. The net result is that it is now possible to depict smaller, more distal pulmonary arteries, comparable even to spiral CTA (computed tomographic angiography) but without incurring the risks associated with the intravenous administration of a large bolus of iodinated contrast (Figure 2.1).

Keywords

Pulmonary Artery Equilibrium Phase Data Respiratory Motion Artifact Distal Pulmonary Artery Pulmonary Arteriography 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alley MT, Shifrin RY, Pelc NJ, Herfkens RJ. Ultrafast contrast-enhanced three-dimensional MR angiography: state of the art. Radiographies 1998; 18 (2): 273–285.Google Scholar
  2. Bongartz G, Boos M, Scheffler K, Steinbrich W. Pulmonary circulation. Eur Radiol 1998; 46 (3): 280–286.Google Scholar
  3. Eisenhauer MD, Kinney JB Jr, Ho VB, Sahn DJ, Braxton M, Peake J. Preoperative gadolinium-enhanced magnetic resonance pulmonary venography in an adolescent with atrial septal defect [published erratum appears in Mil Med 1997; 162:preceding 643]. Mil Med 1997; 162: 640–642.PubMedGoogle Scholar
  4. Gefter WB, Hatabu H, Holland GA, Gupta KB, Henschke CI, Palevsky HI. Pulmonary thromboembolism: recent developments in diagnosis with CT and MR imaging. Radiology 1995; 197: 561–574.PubMedGoogle Scholar
  5. Grist TM, Sostman HD, MacFall JR, Foo TK, Spritzer CE, Witty L, Newman GE, Debatin JF, Tapson V, Saltzman HA. Pulmonary angiography with MR imaging: preliminary clinical experience. Radiology 1993; 189: 523PubMedGoogle Scholar
  6. Hany TF, Schmidt M, Steiner P, Debatin JF. Optimization of contrast dosage for gadolinium-enhanced 3D MRA of the pulmonary and renal arteries. Magn Reson Imaging 1998 (in press).Google Scholar
  7. Hatabu H. MR pulmonary angiography and perfusion imaging: recent advances. Semin Ultrasound CT MR 1997; 18: 349–61.PubMedCrossRefGoogle Scholar
  8. Hatabu H, Gaa J, Kim D, Li W, Prasad PV, Edelman RR. Pulmonary perfusion and angiography: evaluation with breath-hold enhanced three-dimensional fast imaging steady-state precession MR imaging with short TR and TE. AJR Am J Roentgenol 1996; 167: 653–655.PubMedGoogle Scholar
  9. Hudson ER, Smith TP, McDermott VG, Newman GE, Suhocki PV, Payne CS, Stackhouse DJ. Pulmonary angiography performed with iopamidol: complications in 1,434 patients. Radiology 1996; 198: 61–65.PubMedGoogle Scholar
  10. Isoda H, Ushimi T, Masui T, Mochizuki T, Goto S, Suzuki K, Shirakawa T, Ohta A, Takahashe M, Kaneko M. Clinical evaluation of pulmonary 3-D time-of-flight MRA with breath holding using contrast media. J Comput Assist Tomogr 1995; 19: 911–919.PubMedCrossRefGoogle Scholar
  11. Ito T, Takahashi H, Ida M, Kato H. [Evaluation of hilar pulmonary vessels using magnetic resonance angiography (MRA)]. Journal of the Japanese Association for Thoracic Surgery 1998; 46 (3): 280–286.Google Scholar
  12. Kacl GM, Follath F, Salomon F, Debatin JF. Primary angiosarcoma of the pulmonary arteries: dynamic contrast-enhanced MRI. J Comput Assist Tomogr 1998 (in press).Google Scholar
  13. Ladd ME, Goehde SC, Steiner P, Pfamatter T, McKinnon GC, Debatin JF. Virtual MR angioscopy of the pulmonary tree. J Comput Assist Tomogr 1996, 20: 782–785.PubMedCrossRefGoogle Scholar
  14. MacFall JR, Sostman HD, Foo TK. Thick-section, single breath-hold magnetic resonance pulmonary angiography. Invest Radiol 1992; 27: 318–322.PubMedCrossRefGoogle Scholar
  15. Meaney JF, Weg JG, Chenevert TL, Stafford-Johnson D, Hamilton BH, Prince MR. Diagnosis of pulmonary embolism with magnetic resonance angiography [see comments]. NEJM 1997; 336: 1422–1427.PubMedCrossRefGoogle Scholar
  16. Rafal RB, Nichols JN, Markisz JA. Pulmonary artery sarcoma: diagnosis and postoperative follow-up with gadolinium-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. Mayo Clin Proc 1995; 70: 173–176.PubMedCrossRefGoogle Scholar
  17. Steiner P, McKinnon GC, Romanowski BJ, Goehde SC, Hany TF, Debatin JF. Contrast-enhanced, ultrafast 3D pulmonary MR angiography in a single breathhold: initial assessment of imaging performance. J Magn Reson Imaging, 1997; 7: 177–182.PubMedCrossRefGoogle Scholar
  18. Wolff K, Bergin CJ, King MA, Ghadishah E, Sung DW, Clopton P, Bookstein JJ, Auger WR, Moser KM. Accuracy of contrast-enhanced magnetic resonance angiography in chronic thromboembolic disease. Acad Radiol 1996; 3 (1): 10–17.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • Martin R. Prince
    • 1
  • Thomas M. Grist
    • 2
  • Jörg F. Debatin
    • 3
  1. 1.University of MichiganAnn ArborUSA
  2. 2.Department of RadiologyUniversity of Wisconsin — MadisonMadisonUSA
  3. 3.Institute of Diagnostic RadiologyZurich University HospitalZurichSwitzerland

Personalised recommendations